- Home
- PHAT vs ATNI Comparison
PHAT vs ATNI Comparison
Compare PHAT & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- ATNI
- Stock Information
- Founded
- PHAT 2018
- ATNI 1987
- Country
- PHAT United States
- ATNI United States
- Employees
- PHAT N/A
- ATNI N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- ATNI Telecommunications Equipment
- Sector
- PHAT Health Care
- ATNI Telecommunications
- Exchange
- PHAT Nasdaq
- ATNI Nasdaq
- Market Cap
- PHAT 339.8M
- ATNI 312.7M
- IPO Year
- PHAT 2019
- ATNI 1991
- Fundamental
- Price
- PHAT $3.96
- ATNI $17.53
- Analyst Decision
- PHAT Strong Buy
- ATNI Strong Buy
- Analyst Count
- PHAT 5
- ATNI 2
- Target Price
- PHAT $22.50
- ATNI $31.00
- AVG Volume (30 Days)
- PHAT 1.2M
- ATNI 55.9K
- Earning Date
- PHAT 05-08-2025
- ATNI 04-30-2025
- Dividend Yield
- PHAT N/A
- ATNI 5.53%
- EPS Growth
- PHAT N/A
- ATNI N/A
- EPS
- PHAT N/A
- ATNI N/A
- Revenue
- PHAT $55,252,000.00
- ATNI $729,075,000.00
- Revenue This Year
- PHAT $202.23
- ATNI $1.85
- Revenue Next Year
- PHAT $113.81
- ATNI $1.51
- P/E Ratio
- PHAT N/A
- ATNI N/A
- Revenue Growth
- PHAT 8001.47
- ATNI N/A
- 52 Week Low
- PHAT $3.81
- ATNI $14.74
- 52 Week High
- PHAT $19.71
- ATNI $33.72
- Technical
- Relative Strength Index (RSI)
- PHAT 37.83
- ATNI 38.47
- Support Level
- PHAT $3.87
- ATNI $17.41
- Resistance Level
- PHAT $5.09
- ATNI $18.32
- Average True Range (ATR)
- PHAT 0.59
- ATNI 1.02
- MACD
- PHAT -0.10
- ATNI -0.18
- Stochastic Oscillator
- PHAT 6.12
- ATNI 18.42
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.